MedTrace Logo

Mitochondrial Methylation in Type 2 Diabetes

NCT04126551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2024-05-07

No results posted yet for this study

Summary

The overarching goal of this proposal is to determine whether DNA methylation of the mitochondrial DNA impairs mitochondrial function in insulin resistant states such as overweight/obesity and type 2 diabetes.

Conditions

Interventions

OTHER

Methylation status

Participants will be recruited, and muscle biopsies will be obtained for methylation analyses and measuring mitochondrial function

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Principal Investigators

  • Dawn K Coletta, PhD · University of Arizona

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-23
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126551 on ClinicalTrials.gov